Virosome-based nanovaccines; a promising bioinspiration and biomimetic approach for preventing viral diseases: A review
Vaccination is the most effective means of controlling infectious disease-related morbidity
and mortality. However, due to low immunogenicity of viral antigens, nanomedicine as a …
and mortality. However, due to low immunogenicity of viral antigens, nanomedicine as a …
[HTML][HTML] Nano-microparticle platforms in developing next-generation vaccines
The first vaccines ever made were based on live-attenuated or inactivated pathogens, either
whole cells or fragments. Although these vaccines required the co-administration of antigens …
whole cells or fragments. Although these vaccines required the co-administration of antigens …
[HTML][HTML] Emerging vaccine nanotechnology: from defense against infection to sniping cancer
Looking retrospectively at the development of humanity, vaccination is an unprecedented
medical landmark that saves lives by harnessing the human immune system. During the …
medical landmark that saves lives by harnessing the human immune system. During the …
Recent advances in nanotechnology-based COVID-19 vaccines and therapeutic antibodies
COVID-19 has caused a global pandemic and millions of deaths. It is imperative to develop
effective countermeasures against the causative viral agent, SARS-CoV-2 and its many …
effective countermeasures against the causative viral agent, SARS-CoV-2 and its many …
[HTML][HTML] Nanomedicine strategies to target coronavirus
With the severe acute respiratory syndrome coronavirus (SARS-CoV) in 2002, the middle
east respiratory syndrome CoV (MERS-CoV) in 2012 and the recently discovered SARS …
east respiratory syndrome CoV (MERS-CoV) in 2012 and the recently discovered SARS …
[HTML][HTML] COVID-19 vaccine development and a potential nanomaterial path forward
MD Shin, S Shukla, YH Chung, V Beiss… - Nature …, 2020 - nature.com
The COVID-19 pandemic has infected millions of people with no clear signs of abatement
owing to the high prevalence, long incubation period and lack of established treatments or …
owing to the high prevalence, long incubation period and lack of established treatments or …
[HTML][HTML] Virus-like particles: preparation, immunogenicity and their roles as nanovaccines and drug nanocarriers
S Nooraei, H Bahrulolum, ZS Hoseini… - Journal of …, 2021 - Springer
Virus-like particles (VLPs) are virus-derived structures made up of one or more different
molecules with the ability to self-assemble, mimicking the form and size of a virus particle but …
molecules with the ability to self-assemble, mimicking the form and size of a virus particle but …
[HTML][HTML] Possibility of exosome‑based coronavirus disease 2019 vaccine
KH Yoo, N Thapa, BJ Kim, JO Lee… - Molecular …, 2022 - spandidos-publications.com
Abstract Coronavirus disease 2019 (COVID‑19) is a global pandemic that can have a long‑
lasting impact on public health if not properly managed. Ongoing vaccine development trials …
lasting impact on public health if not properly managed. Ongoing vaccine development trials …
[HTML][HTML] Nanovaccines: a game changing approach in the fight against infectious diseases
The field of nanotechnology has revolutionised global attempts to prevent, treat, and
eradicate infectious diseases in the foreseen future. Nanovaccines have proven to be a …
eradicate infectious diseases in the foreseen future. Nanovaccines have proven to be a …
[HTML][HTML] Nanocarrier vaccine therapeutics for global infectious and chronic diseases
Immunization has the potential to become a viable weapon for the upcoming pandemic and
save millions of lives, while also dramatically lowering the high mortality rate brought on by a …
save millions of lives, while also dramatically lowering the high mortality rate brought on by a …